EGAN
eGain Corporation
EGAN trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over EGAN overall, supported by stronger valuation and stronger modeled upside.
EGAN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Unavailable |
EGAN's cash flow is currently strong, and its revenue and profitability are stable. There isn't enough data to rate its balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
EGAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $4.11 | -33% |
| Current | 22x | $6.10 | — |
| Fair | 46x | $12.76 | +109% |
| Expensive | 67x | $18.84 | +209% |
Historical ranges are pointers, not guarantees.
EGAN's PE is 22x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over EGAN in the historical PE scenario, which offers more potential upside but is not a forecast.
EGAN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect EGAN's earnings and profitability to decline, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
NVDA has the edge over EGAN on the outlook, with more favorable earnings and revenue expectations.
EGAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.28 | -77% |
EGAN earned $0.28 per share over the past year, down 77% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over EGAN in the latest year-over-year earnings comparison.
EGAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.9M | -7% |
| Q2 2026 | $22.2M | -4.7% |
| Q1 2026 | $22.5M | +7.1% |
| Q4 2025 | $23M | +2.6% |
EGAN's revenue has held roughly level: $22M last quarter, down 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.9% | -9.1 points |
| Q1 2026 | 8.9% | +8.8 points |
| Q4 2025 | 8.9% | +6 points |
| Q3 2025 | 12% | N/A |
| Q2 2025 | 14% | N/A |
| Q1 2025 | 0.1% | N/A |
| Q4 2024 | 2.9% | N/A |
EGAN's operating margin was 4.9% last quarter, down 9.1 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over EGAN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over EGAN on profitability, with a higher operating margin.
EGAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.3M | +$6.9M |
| Q1 2026 | -$1.9M | -189% |
| Q4 2025 | $9.9M | +57% |
EGAN and NVDA do not have enough comparable growth data to identify a winner.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
EGAN Net Leverage
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
EGAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.7 | Neutral |
| Stochastic | 37.3 | Neutral |
EGAN's weekly RSI is 45 (neutral) and its Stochastic is 37 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
EGAN PE vs Technology Sector
| Metric | EGAN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 28x | 22% below |
| PE % | 24 | 35 | 11 pts below |
EGAN is trading at 22x earnings, a 22% discount to the Technology sector's median of 28x, though its earnings don't support one.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over EGAN on valuation relative to its sector.
EGAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.78 | 5.5% above |
| 20 week MA | $6.25 | 2.4% below |
| 50 week MA | $7.74 | 21% below |
| 100 week MA | $7.43 | 18% below |
| 200 week MA | $7.09 | 14% below |
EGAN has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 14% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
EGAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.11 | $12.6 | +55% |
| 2021 | $12.6 | $10.2 | -19% |
| 2022 | $10.2 | $8.85 | -13% |
| 2023 | $8.85 | $8.33 | -5.9% |
| 2024 | $8.33 | $6.29 | -24% |
| 2025 | $6.29 | $10.5 | +67% |
| 2026 YTD | $10.5 | $6.10 | -42% |
EGAN has finished lower in four of the last six years. It's down 42% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over EGAN on returns for 2026, with the stronger performance.